Image For Activity Cover
Novel Diabetes Medications and Retinopathy Recording
Overview
Join other American Diabetes Association® (ADA) professional members for a live, one-hour webinar, Novel Diabetes Medications and Diabetic Retinopathy. In this webinar, we will will focus on GLP1 and ophthalmic risk.
Learning Objectives
  • Discuss novel diabetes medications (GLP1, SGLT2, etc) and diabetic retinopathy
  • Recognizing nonarteritic anterior ischemic optic neuropathy in people with diabetes
Speaker
Andrew J. Barkmeier, M.D.
Mayo Clinic
Moderators
Blake Cooper, MD, MPH
Retina Associates

Risa Wolf, MD
John Hopkins University School of Medicine
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright All rights reserved.
Android App Download IOS App Download Powered By